By PETER J. HENNING and STEVEN DAVIDOFF SOLOMON
The claims in Allergan’s lawsuit against Valeant and William Ackman are of the ho-hum type that targets often raise to fend off – or at least slow down – a bidder, write Peter J. Henning and Steven Davidoff Solomon.
Published: August 1, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1tDJVR5
from WordPress http://ift.tt/1rSYVGI
via Hadi Aboukhater
No comments:
Post a Comment